GA

Gold-Zack AG

Europe, Nordrhein-Westfalen, Germany, Mettmann

Description

Gold-Zack AG is a European investment group for small- and medium-sized companies in growth markets.

Investor Profile

Gold-Zack AG has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (50%)
  • Series C (50%)

Country Focus

  • Germany (50%)
  • United States (50%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Genetics
  • Medical
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gold-Zack AG frequently co-invest with?

IKB Deutsche Industriebank
Europe, Nordrhein-Westfalen, Germany, Düsseldorf
Co-Investments: 1
AlpInvest Partners
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Excalibur Fund Managers
Europe, England, United Kingdom, London
Co-Investments: 1
ITX Corporation
North America, New York, United States, Pittsford
Co-Investments: 1
Vontobel
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Techno Venture Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Deutsche Venture Capital
Europe, Bayern, Germany, München
Co-Investments: 1
MB
Europe, Hamburg, Germany, Hamburg
Co-Investments: 1

What are some of recent deals done by Gold-Zack AG?

Cardion

Erkrath, Nordrhein-Westfalen, Germany

Cardion is a biopharmaceutical company that develops cardiovascular gene therapy products.

BiopharmaBiotechnologyGeneticsMedical
Series UnknownSep 23, 2002
Amount Raised: $11,271,482
EpiCept Corporation

Englewood Cliffs, New Jersey, United States

EpiCept Corporation an emerging leader in pain management.

Information Technology
Series CJan 10, 2001
Amount Raised: $13,000,000